Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 35% ± 18% | |
GABAergic neuron | 8 studies | 35% ± 19% | |
neuron | 7 studies | 34% ± 11% | |
interneuron | 7 studies | 39% ± 17% | |
astrocyte | 6 studies | 22% ± 5% | |
OFF-bipolar cell | 5 studies | 31% ± 10% | |
retinal bipolar neuron | 4 studies | 32% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 9% | |
retinal ganglion cell | 4 studies | 60% ± 26% | |
amacrine cell | 4 studies | 30% ± 9% | |
adventitial cell | 4 studies | 21% ± 3% | |
GABAergic interneuron | 3 studies | 26% ± 10% | |
glial cell | 3 studies | 19% ± 0% | |
granule cell | 3 studies | 41% ± 7% | |
ON-bipolar cell | 3 studies | 33% ± 8% | |
fibroblast | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 12555.31 | 2601 / 2642 | 98% | 80.22 | 692 / 705 |
skin | 56% | 2918.09 | 1021 / 1809 | 28% | 7.07 | 130 / 472 |
intestine | 71% | 1709.20 | 682 / 966 | 4% | 0.33 | 20 / 527 |
lymph node | 0% | 0 | 0 / 0 | 72% | 5.99 | 21 / 29 |
esophagus | 62% | 1324.31 | 897 / 1445 | 7% | 0.48 | 12 / 183 |
bladder | 57% | 969.43 | 12 / 21 | 8% | 0.94 | 40 / 504 |
adipose | 53% | 1018.86 | 641 / 1204 | 0% | 0 | 0 / 0 |
breast | 33% | 485.70 | 150 / 459 | 15% | 1.31 | 169 / 1118 |
adrenal gland | 1% | 43.59 | 3 / 258 | 45% | 15.89 | 103 / 230 |
ovary | 1% | 16.39 | 2 / 180 | 44% | 8.70 | 190 / 430 |
stomach | 31% | 589.87 | 113 / 359 | 7% | 0.55 | 20 / 286 |
kidney | 4% | 107.94 | 4 / 89 | 31% | 8.56 | 283 / 901 |
thymus | 4% | 53.75 | 24 / 653 | 29% | 4.57 | 176 / 605 |
pancreas | 0% | 0 | 0 / 328 | 26% | 2.01 | 46 / 178 |
heart | 24% | 431.51 | 209 / 861 | 0% | 0 | 0 / 0 |
lung | 9% | 136.97 | 50 / 578 | 12% | 1.38 | 133 / 1155 |
uterus | 9% | 212.19 | 16 / 170 | 10% | 1.76 | 45 / 459 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.91 | 8 / 45 |
prostate | 10% | 159.80 | 24 / 245 | 8% | 0.45 | 40 / 502 |
blood vessel | 15% | 286.44 | 204 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 1.83 | 6 / 80 |
liver | 0% | 0 | 0 / 226 | 2% | 0.19 | 10 / 406 |
muscle | 0% | 1.92 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007157 | Biological process | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CADM3 |
Protein name | Cell adhesion molecule 3 Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1) |
Synonyms | UNQ225/PRO258 SYNCAM3 NECL1 IGSF4B TSLL1 |
Description | FUNCTION: Involved in the cell-cell adhesion. Has both calcium-independent homophilic cell-cell adhesion activity and calcium-independent heterophilic cell-cell adhesion activity with IGSF4, NECTIN1 and NECTIN3. Interaction with EPB41L1 may regulate structure or function of cell-cell junctions (By similarity). . |
Accessions | Q8N126 ENST00000368125.9 [Q8N126-1] ENST00000368124.8 [Q8N126-2] ENST00000416746.1 A0A0C4DG09 |